Home/Filings/4/0001144204-17-018880
4//SEC Filing

Protea Biosciences Group, Inc. 4

Accession 0001144204-17-018880

CIK 0001335103operating

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 4:28 PM ET

Size

12.7 KB

Accession

0001144204-17-018880

Insider Transaction Report

Form 4
Period: 2017-03-24
ANTOLINE STEVE
Director10% Owner
Transactions
  • Other

    Common Stock

    2017-03-24+16,564,24826,325,894 total(indirect: Summit Resources, Inc.)
  • Other

    Class A Warrant (right to buy)

    2017-03-24+16,564,24842,422,699 total(indirect: Summit Resources, Inc.)
    Exercise: $0.09From: 2017-03-24Exp: 2018-09-24Common Stock (16,564,248 underlying)
  • Other

    Class B Warrant (right to buy)

    2017-03-24+16,564,24842,422,699 total(indirect: Summit Resources, Inc.)
    Exercise: $0.11From: 2017-03-24Exp: 2022-03-24Common Stock (16,564,248 underlying)
Footnotes (5)
  • [F1]Summit Resources, Inc., an affiliate of Mr. Antoline, held $1,242,318.55 of outstanding principal indebtedness and accrued unpaid interest of the Issuer ("Unsecured Debt"). On March 24, 2017, Mr. Antoline exchanged $1,242,318.55 of Unsecured Debt of the Issuer, for units of the Issuer's equity securities, consisting of (a) an aggregate of 16,564,248 shares of common stock, $0.0001 par value per share, of the Issuer ("Common Stock") valued at $0.075 per share, (b) 18 month Class A warrants to purchase 16,564,248 shares of Common Stock at an exercise price of $0.09 per share, and (c) five year Class B warrants to purchase another 16,564,248 shares at an exercise price of $0.1125 per share.
  • [F2]The shares of Common Stock reported in Column 5 and 7 are the number of shares of Common Stock issuable upon exercise of the Class A Warrant and/or Class B Warrant (collectively, "Warrants").
  • [F3]Includes 1,514,048 shares of Common Stock owned of record and beneficially by Wilderness Land Company, LLC, and 24,811,846 shares of Common Stock owned of record and beneficially by Summit Resources, Inc.
  • [F4]Includes 166,667 shares of Common Stock to be acquired upon the exercise of stock options held as of record and beneficially by Mr. Antoline. Also includes 42,089,365 shares of Common Stock to be acquired upon the exercise of warrants held as of record and beneficially by Summit Resources, Inc., and 166,667 shares of Common Stock to be acquired upon the exercise of stock options held as of record and beneficially by Summit Resources, Inc.
  • [F5]As president of Summit Resources, Inc., Mr. Antoline has voting and dispositive control over any securities owned of record by Summit Resources, Inc. Therefore, he also may be deemed to beneficially own the shares of common stock and the shares of common stock to be acquired upon the exercise of warrants held of record by the Summit Resources, Inc. As the trustee of the Wilderness Land Company, LLC, Mr. Antoline has voting and dispositive control over any securities owned of record by the Wilderness Land Company. Therefore, he may be deemed to beneficially own the shares of common stock and the shares of common stock to be acquired upon the exercise of warrants held of record by the Wilderness Land Company, LLC.

Issuer

Protea Biosciences Group, Inc.

CIK 0001335103

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001335103

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:28 PM ET
Size
12.7 KB